These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18098290)

  • 1. The combination of epigallocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivo.
    Somers-Edgar TJ; Scandlyn MJ; Stuart EC; Le Nedelec MJ; Valentine SP; Rosengren RJ
    Int J Cancer; 2008 May; 122(9):1966-71. PubMed ID: 18098290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate.
    Scandlyn MJ; Stuart EC; Somers-Edgar TJ; Menzies AR; Rosengren RJ
    Br J Cancer; 2008 Oct; 99(7):1056-63. PubMed ID: 18797454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of raloxifene and epigallocatechin gallate suppresses growth and induces apoptosis in MDA-MB-231 cells.
    Stuart EC; Rosengren RJ
    Life Sci; 2008 Apr; 82(17-18):943-8. PubMed ID: 18371987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of low concentration of (-)-epigallocatechin gallate (EGCG) and curcumin strongly suppresses the growth of non-small cell lung cancer in vitro and in vivo through causing cell cycle arrest.
    Zhou DH; Wang X; Yang M; Shi X; Huang W; Feng Q
    Int J Mol Sci; 2013 Jun; 14(6):12023-36. PubMed ID: 23739680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential mechanisms for the synergistic cytotoxicity elicited by 4-hydroxytamoxifen and epigallocatechin gallate in MDA-MB-231 cells.
    Stuart EC; Larsen L; Rosengren RJ
    Int J Oncol; 2007 Jun; 30(6):1407-12. PubMed ID: 17487361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells.
    Eom DW; Lee JH; Kim YJ; Hwang GS; Kim SN; Kwak JH; Cheon GJ; Kim KH; Jang HJ; Ham J; Kang KS; Yamabe N
    BMB Rep; 2015 Aug; 48(8):461-6. PubMed ID: 25441423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro mechanism of action for the cytotoxicity elicited by the combination of epigallocatechin gallate and raloxifene in MDA-MB-231 cells.
    Stuart EC; Jarvis RM; Rosengren RJ
    Oncol Rep; 2010 Sep; 24(3):779-85. PubMed ID: 20664987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor-α36 is involved in epigallocatechin-3-gallate induced growth inhibition of ER-negative breast cancer stem/progenitor cells.
    Pan X; Zhao B; Song Z; Han S; Wang M
    J Pharmacol Sci; 2016 Feb; 130(2):85-93. PubMed ID: 26810571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells.
    Wang S; Chen R; Zhong Z; Shi Z; Chen M; Wang Y
    Am J Chin Med; 2014; 42(5):1279-300. PubMed ID: 25242081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models.
    Yadav B; Taurin S; Larsen L; Rosengren RJ
    Int J Oncol; 2012 Nov; 41(5):1723-32. PubMed ID: 22971638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling.
    Chung SS; Vadgama JV
    Anticancer Res; 2015 Jan; 35(1):39-46. PubMed ID: 25550533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
    Farabegoli F; Papi A; Orlandi M
    Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression.
    Ahn WS; Huh SW; Bae SM; Lee IP; Lee JM; Namkoong SE; Kim CK; Sin JI
    DNA Cell Biol; 2003 Mar; 22(3):217-24. PubMed ID: 12804120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells.
    Hsieh TC; Wu JM
    Int J Oncol; 2008 Oct; 33(4):851-9. PubMed ID: 18813800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
    Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
    Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells.
    Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Kubota M; Adachi S; Tsurumi H; Hara Y; Moriwaki H
    Chem Biol Interact; 2010 May; 185(3):247-52. PubMed ID: 20346928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
    Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
    Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC; Lin-Shiau SY; Chen CF; Lin JK
    J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
    Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
    Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.